Concepedia

Diana Klimaszewska

DK

Statistics

Publications

5

Citations

282

H-Index

5

Active since

2021

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Age UK

University of Strathclyde

University College London

GlaxoSmithKline (United States)

Diana Klimaszewska is an author at GlaxoSmithKline (United Kingdom) specializing in drug discovery, pharmacology, and medicinal chemistry applications.

Publications per year

2021–2024

5

Publications

5

Discovery and Characterisation of Highly Cooperative FAK‐Degrading PROTACs

Robert P. Law, João Nunes, Chun‐wa Chung et al. · Angewandte Chemie International Edition · 2021 · 116 citations

, , +11

Integrated Direct-to-Biology Platform for the Nanoscale Synthesis and Biological Evaluation of PROTACs

Rebecca Stevens, Enrique Bendito-Moll, David Battersby et al. · Journal of Medicinal Chemistry · 2023 · 65 citations

, , +10

Development of a small molecule that corrects misfolding and increases secretion of Z α1‐antitrypsin

David A. Lomas, James A. Irving, Christopher C. Arico-Muendel et al. · EMBO Molecular Medicine · 2021 · 64 citations · Full text

, , +8

Expanding the reaction toolbox for nanoscale direct-to-biology PROTAC synthesis and biological evaluation

Rebecca Stevens, Harry J. Shrives, Jenni Cryan et al. · RSC Medicinal Chemistry · 2024 · 23 citations · Full text

, , +9

The development of highly potent and selective small molecule correctors of Z α1-antitrypsin misfolding

John Liddle, Andrew C. Pearce, Christopher C. Arico-Muendel et al. · Bioorganic & Medicinal Chemistry Letters · 2021 · 14 citations · Full text

, , +14

1–5 of 5